SEC Filing: Form 10-Q
Quarterly report [Sections 13 or 15(d)]
VYNE TherapeuticsRooted in Innovation
VYNE Therapeutics
Quarterly report [Sections 13 or 15(d)]
Statement of changes in beneficial ownership of securities
Statement of changes in beneficial ownership of securities
Statement of changes in beneficial ownership of securities
Statement of changes in beneficial ownership of securities
Current report